These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 2561990)
1. Pharmacologic implications of alpha-adrenoreceptor interactive parameters for epinephrine enantiomers in the rat vas deferens. Rice PJ; Miller DD; Sokoloski TD; Patil PN Chirality; 1989; 1(1):14-9. PubMed ID: 2561990 [TBL] [Abstract][Full Text] [Related]
2. Epinephrine enantiomers: affinity, efficacy and potency relationships in rat smooth muscle tissues. Rice PJ; Miller DD; Patil PN J Pharmacol Exp Ther; 1989 Apr; 249(1):242-8. PubMed ID: 2540314 [TBL] [Abstract][Full Text] [Related]
3. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Minneman KP; Abel PW Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist. Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368 [TBL] [Abstract][Full Text] [Related]
5. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens. Minneman KP; Fox AW; Abel PW Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645 [TBL] [Abstract][Full Text] [Related]
6. Sympathetic denervation does not alter the density or properties of alpha-1 adrenergic receptors in rat vas deferens. Abel PW; Johnson RD; Martin TJ; Minneman KP J Pharmacol Exp Ther; 1985 Jun; 233(3):570-7. PubMed ID: 2989488 [TBL] [Abstract][Full Text] [Related]
7. Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors. Nasseri A; Barakeh JF; Abel PW; Minneman KP J Pharmacol Exp Ther; 1985 Aug; 234(2):350-7. PubMed ID: 2991496 [TBL] [Abstract][Full Text] [Related]
8. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Morrow AL; Creese I Mol Pharmacol; 1986 Apr; 29(4):321-30. PubMed ID: 3010073 [TBL] [Abstract][Full Text] [Related]
9. Effects of isoxuprine and nylidrin on adrenoreceptors in rat vas deferens. Abel PW; Fox AW; Minneman KP J Auton Pharmacol; 1985 Sep; 5(3):213-9. PubMed ID: 2997229 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes. Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105 [TBL] [Abstract][Full Text] [Related]
12. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors. Convents A; De Backer JP; Convents D; Vauquelin G Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739 [TBL] [Abstract][Full Text] [Related]
13. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor. Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547 [TBL] [Abstract][Full Text] [Related]
15. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176 [TBL] [Abstract][Full Text] [Related]
16. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens. Wilberding CA; Marks BH Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):387-401. PubMed ID: 6265988 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity. Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758 [TBL] [Abstract][Full Text] [Related]
18. Postsynaptic alpha adrenergic receptor subtypes differentiated by yohimbine in tissues from the rat. Existence of alpha-2 adrenergic receptors in rat aorta. Ruffolo RR; Waddell JE; Yaden EL J Pharmacol Exp Ther; 1981 May; 217(2):235-40. PubMed ID: 6262479 [TBL] [Abstract][Full Text] [Related]
19. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548 [TBL] [Abstract][Full Text] [Related]
20. The classical competitive antagonism of phentolamine on smooth muscle preparations, investigated by two procedures. Patil PN Auton Autacoid Pharmacol; 2007 Jan; 27(1):71-7. PubMed ID: 17199878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]